Dow Up 0.00% Nasdaq Up 0.09%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
7.11 Down 0.18(2.47%) Nov 28, 1:00PM EST
Prev Close:7.29
Open:7.38
Bid:N/A
Ask:9.16 x 100
1y Target Est:8.28
Beta:0.78
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:7.07 - 7.48
52wk Range:3.80 - 9.83
Volume:4,531,780
Avg Vol (3m):6,393,920
Market Cap:1.33B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 2.47%1.33B
NVSUp 1.14%233.77B
PFEUp 0.16%196.27B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.10
Quarterly EPS Est (Dec-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback